Regeneron Sets Foot in Hyderabad: A New Era for Global Life Sciences

Regeneron Pharmaceuticals has announced plans to establish its Global Capability Centre (GCC) in Hyderabad, India, set to be operational by the latter half of 2026. The new GCC will heavily bolster Regeneron's operations through advancements in areas like data management, artificial intelligence, and clinical trials, generating hundreds of new roles.

US-based Regeneron Pharmaceuticals revealed its plan to inaugurate a Global Capability Centre (GCC) in Hyderabad by mid-2026. This strategic expansion aims to augment its reach in India's burgeoning life sciences sector.

The upcoming GCC is poised to create numerous jobs and support various facets of Regeneron’s global operations, including data management, AI, and clinical trials. This move further entrenches Hyderabad as a pivotal life sciences hub.

Telangana's IT and Industries Minister, Sridhar Babu, lauds the investment as a boon for the state’s life sciences ecosystem, aligning with Hyderabad’s growing prominence in pharmaceuticals and biotechnology.